KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead Sciences Javascript is ...
Stay confident in today’s economy with useful tips and enter our $26K Sweepstakes! Help Register Login Login Hi, %{firstName} ...
Objectives To compare the effectiveness of different exercise interventions in improving sleep quality and alleviating insomnia severity among patients with insomnia. Design Our study design was a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results